Advertisement
week in cancer news
  • May 31: The Week in Cancer News

    A study finds that oral cancer medication costs for patients covered by Medicare Part D have increased, and the U.S. Food and Drug Administration approves a new targeted therapy for advanced breast cancer.

    by Kate Yandell

  • May 24: The Week in Cancer News

    Unequal access to care appears to be responsible for the elevated mortality rate from prostate cancer in black men, and women with a history of cancer who identify as lesbian or bisexual have reduced access to care.

    by Kate Yandell

  • May 17: The Week in Cancer News

    A study indicates that the Affordable Care Act decreased the proportion of people with a history of cancer who are uninsured, and access to appropriate targeted therapies may be lacking for some patients.

    by Kate Yandell

  • May 10: The Week in Cancer News

    The spread of measles raises concerns among some cancer patients, and a treatment for early-stage HER2-positive breast cancer is approved by the U.S. Food and Drug Administration.

    by Kate Yandell and Bradley Jones

  • The Week in Cancer News: May 3

    Prospective CRISPR application targets cancer directly, HER2 testing accessibility poor in many countries.

    by Bradley Jones

  • April 26: The Week in Cancer News

    A study indicates that the majority of patients using immune checkpoint inhibitors experience side effects, and radiation oncologists say that requirements for prior authorization are impeding care.

    by Kate Yandell

  • April 19: The Week in Cancer News

    The CRISPR gene-editing technique is used for the first time in a U.S. cancer clinical trial, and a new targeted therapy is approved for advanced bladder cancer.

    by Kate Yandell

  • April 12: The Week in Cancer News

    Cancer patients report difficulty getting student loans deferred, and new guidelines for breast cancer screening are released.

    by Kate Yandell

  • April 5: The Week in Cancer News

    People with metastatic cancer call for more research into survivorship issues facing this group, and a study indicates that taking probiotics may interfere with immunotherapy response.

    by Marci A. Landsmann and Kate Yandell

  • March 29: The Week in Cancer News

    Jury awards damages to man who says Roundup caused his cancer, the FDA proposes national standards for breast density notifications, and a physician questions whether patients with impaired renal function should avoid contrast-enhanced scans.

    by Marci A. Landsmann